Dauden, E.
259  results:
Search for persons X
?
4

Psoriasis Severity, Health-Related Quality of Life, Work Pr..:

Daudén, E. ; Vidal, D. ; Romero, A....
Actas Dermo-Sifiliográficas.  115 (2024)  1 - p. 1-9 , 2024
 
?
6

[Artículo traducido] Gravedad de la psoriasis, calidad de v..:

Daudén, E. ; Vidal, D. ; Romero, A....
Actas Dermo-Sifiliográficas.  115 (2024)  1 - p. T1-T9 , 2024
 
?
7

Effectiveness of secukinumab for the treatment of erythrode..:

Reymundo, A. ; Armesto, S. ; Rodríguez, L....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  12 - p. , 2023
 
?
8

Persistence and effectiveness of guselkumab treatment in pa..:

Puig, L. ; Daudén, E. ; Cuervas‐Mons, M...
Journal of the European Academy of Dermatology and Venereology.  , 2023
 
?
 
?
10

Tildrakizumab efficacy and safety in patients with psoriasi..:

Fernandez, A.P. ; Dauden, E. ; Gerdes, S....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  10 - p. 1774-1783 , 2022
 
?
 
?
12

Effectiveness and safety profile of secukinumab for the tre..:

Reymundo, A. ; Vilarrasa, E. ; Baniandrés, O....
Journal of the European Academy of Dermatology and Venereology.  36 (2022)  10 - p. , 2022
 
?
 
?
14

Baseline characteristics of patients with moderate‐to‐sever..:

Augustin, M. ; Dauden, E. ; Mrowietz, U....
Journal of the European Academy of Dermatology and Venereology.  34 (2020)  11 - p. 2548-2556 , 2020
 
?
15

Changing Trends in Drug Prescription and Causes of Treatmen..:

Ruiz-Genao, D.P. ; Carretero, G. ; Rivera, R....
Actas Dermo-Sifiliográficas (English Edition).  111 (2020)  9 - p. 752-760 , 2020
 
1-15